Biotech Values

[Titan V]

MRNS—“PhII data due shortly from i.v. #ganaxolone in PPD $MRNS, the results will be held up against #brexanolone $SAGE, my previous take...”

PhII data due shortly from i.v. #ganaxolone in PPD $MRNS, the results will be held up against #brexanolone $SAGE, my previous take: https://t.co/St4JjRhv7Y

— Joanne Fagg (@ByJoFagg) January 17, 2018

On a side note, for what it’s worth (perhaps zilch), MRNS has not PR’ed a 2018 business outlook like they did for 2017 in the first week of January last year.